from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1121/zwf1

LFCtreatmentdescriptionclass of inhibitor

-1.119

Amikacinug/mL Amikacintranslation

-2.152

Cap5-10ug/mL Capreomycintranslation

-1.612

Rox10-50 ug/mL Roxithromycintranslation

-0.190

SM2-5 ug/mL Streptomycintranslation

0.188

Tet5-10 ug/mL Tetracyclinetranslation

-0.443

Rif0.2-5ug/mL Rifampicintranscription

-0.607

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.397

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.166

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.166

CPZ10-50 ug/mL Chlorpromazinerespiration

0.716

Clofazimine10-13 ug/mL Clofaziminerespiration

0.478

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.766

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.150

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.120

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.628

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.282

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.092

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.266

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.253

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.244

KCN5-20 ug/mL Potassium cyaniderespiration

0.167

NaN30.2-2 mM Sodium aziderespiration

-0.955

Nigericin50 uM Nigericinrespiration

-0.413

TRC10-150 ug/mL Triclosanrespiration

-0.025

TRZ10-25 ug/mL Thioridazinerespiration

0.469

Valinomycin0.5-10 uM Valinomycinrespiration

0.600

ZnSO42 mM ZnSO4respiration

-0.311

menadione6-10 ug/mL Menadionerespiration

-0.250

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.104

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.306

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.335

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.459

NRP_1Non-replicating persistence stage 1dosRassociated

-0.025

Amp0.2mg/mL AmpicillincellWall

0.072

Cephalexin20-100 ug/mL CephalexincellWall

-0.456

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.121

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.122

EMB10-20 ug/mL EthambutolcellWall

0.035

Eta12-40 ug/mL EthionamidecellWall

-0.546

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.410

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.217

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.193

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.016

BZA0.12 mg/mL BenzamidearomaticAmides

-0.125

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.279

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.360

H2O24 mM hydrogen peroxideDNAdamaging

0.647

Levo10 ug/mL LevofloxacinDNAdamaging

0.173

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.387

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.842

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.164

UVUV-irradiationDNAdamaging

-0.593

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.546

Antimycin12.5-50 ug/mL Antimycin A?

0.037

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.037

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.216

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.246

PA8240.2-2 ug/mL PA-824?

1.752

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.791

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.010

Verapamil50 uM Verapamil?

0.113

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.386

methoxatin10-20 ug/mL Methoxatin?